Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-177.86	-10.38	-3.74
Graham Fair Price	23.54	0.15	0.12
PEG	2768.09	0.44	0.02
Price/Book	-105.22	-17.14	-8.35
Price/Cash Flow	-865.24	-66.38	-6.88
Prices/Earnings	-245.12	-2.11	-0.61
Price/Sales	0.00	0.00	0.00
Price/FCF	-865.24	-66.38	-6.88
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00
ROA	-86.03	-0.78	-0.42
ROE	3.42	2.03	-40.54
ROIC	-2.33	20.19	765.59
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	0.51	-83.99
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.41	-0.45	8.09
EPS QOQ	0.40	0.05	-87.97
FCF QOQ	0.67	0.45	-33.45
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	1.65	-9.08	451.83
Quick Ratio	0.16	-0.19	14.06
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-0.01	-0.02	-60.21
Cash	0.01	-0.02	47.21
Capex	0.00	0.00	0.00
Free Cash Flow	-0.02	< 0.005	65.94
Revenue	0.00	0.00	0.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.26	0.14	-47.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.64	-0.92	-43.29
Naive Interpretation	Member

06 - Financial Health · Bad

Rating